| Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease RE Bennett, AB Robbins, M Hu, X Cao, RA Betensky, T Clark, S Das, ... Proceedings of the National Academy of Sciences 115 (6), E1289-E1298, 2018 | 331 | 2018 |
| Experimental evidence for the age dependence of tau protein spread in the brain S Wegmann, RE Bennett, L Delorme, AB Robbins, M Hu, D MacKenzie, ... Science advances 5 (6), eaaw6404, 2019 | 148 | 2019 |
| Partial reduction of microglia does not affect tau pathology in aged mice RE Bennett, A Bryant, M Hu, AB Robbins, SC Hopp, BT Hyman Journal of neuroinflammation 15, 1-11, 2018 | 76 | 2018 |
| Persistent repression of tau in the brain using engineered zinc finger protein transcription factors S Wegmann, SL DeVos, B Zeitler, K Marlen, RE Bennett, M Perez-Rando, ... Science Advances 7 (12), eabe1611, 2021 | 53 | 2021 |
| Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 mice EM Carrell, MS Keiser, AB Robbins, BL Davidson Molecular Therapy Methods & Clinical Development 25, 333-343, 2022 | 13 | 2022 |
| Tau reduction in aged mice does not impact Microangiopathy RE Bennett, M Hu, A Fernandes, M Perez-Rando, A Robbins, T Kamath, ... Acta neuropathologica communications 8 (1), 137, 2020 | 12 | 2020 |
| Ten important roles for academic leaders to promote equity, diversity, and inclusion in data science JH Moore, VQ Truong, AB Robbins, D Nicholson, CL Williams-Devane BioData Mining 14, 1-6, 2021 | 5 | 2021 |
| AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALS DA Amado, AB Robbins, AR Smith, KR Whiteman, G Chillon Bosch, ... bioRxiv, 2024.01. 31.578314, 2024 | 3 | 2024 |
| AAV Capsid Selection at Spatial and Single-Cell Resolution in Non-Human Primate Retina A Robbins, Y Chen, B Lewandowski, D Houserova, PT Ranum, L Tecedor, ... MOLECULAR THERAPY 32 (4), 166-167, 2024 | | 2024 |
| Novel AAV Variants for Huntington's Disease Gene Therapy B Lewandowski, DE Leib, Y Chen, PT Ranum, L Tecedor, S Arora, ... MOLECULAR THERAPY 32 (4), 474-474, 2024 | | 2024 |
| Improved Survival, Strength, Weight, and Neuroinflammation in a Mouse Model of Sporadic ALS after Novel AAV-Mediated Delivery of RNAi Targeting Atxn2 DA Amado, K Whiteman, AR Smith, GC Bosch, AM Monteys, A Robbins, ... ANNALS OF NEUROLOGY 94, S217-S218, 2023 | | 2023 |
| Improved Survival, Strength, And Neuroinflammation In A Mouse Model Of Sporadic ALS After Novel AAV-mediated Delivery Of RNAi TargetingAtxn2 DA Amado, AM Monteys, AR Smith, K Whiteman, GC Bosch, A Robbins, ... ANNALS OF NEUROLOGY 94, S221-S221, 2023 | | 2023 |
| Comparative Transcriptomic Analysis Identifies Rescue of Dysregulated Signatures by ATXN1 Knockdown and ATXN1L Overexpression in a Mouse Model of SCA1 A Robbins, E Carrell, MS Keiser, BL Davidson MOLECULAR THERAPY 31 (4), 148-148, 2023 | | 2023 |
| In Vivo AAV Capsid Selection at Spatial and Single-Cell Resolution AB Robbins, PT Ranum, Y Chen, MS Keiser, L Tecedor, BL Davidson MOLECULAR THERAPY 31 (4), 22-22, 2023 | | 2023 |
| Combined Overexpression of hATXN1L and Mutant ATXN1 Knockdown Rescues Motor Phenotypes and Disease-Related Gene Expression Changes in B05 Mice AB Robbins, EM Carrell, MS Keiser, BL Davidson MOLECULAR THERAPY 30 (4), 111-111, 2022 | | 2022 |
